Design of high-affinity major histocompatibility complex-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: implications for control of viral disease.

Source:http://linkedlifedata.com/resource/pubmed/id/1383569

Download in:

View as

General Info

PMID
1383569